{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:55:17Z","timestamp":1791903317777,"version":"4.3.4"},"reference-count":35,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) is multifactorial, and established hereditary risk factors explain only part of heritable risk. The protein C (PC) pathway is central to anticoagulant control, and common variants in thrombomodulin and endothelial PC receptor genes (THBD, PROCR) have been proposed as modulators. In 73 participants, we used standardized in vivo coagulation activation with recombinant activated factor VII (15 \u03bcg\/kg) and measured thrombin markers and activated PC (APC) over 8 hours. Endothelial colony-forming cell\u2013based ex vivo experiments were performed in 43 participants. In vivo, the ratio of APC area under the curve (AUC) to thrombin-antithrombin complex (TAT) AUC, which reflects the endogenous anticoagulant response relative to thrombin generation, provided the best model fit (adjusted R2 = 0.345). The APC response was lower in individuals with previous VTE (median, 0.13 vs 0.26) and PROCR 655A&amp;gt;G carriers (0.11 vs 0.26), but higher in factor V Leiden (FVL) carriers (0.32 vs 0.14) and THBD 1418C&amp;gt;T carriers (0.38 vs 0.13). The THBD 1418C&amp;gt;T effect was driven by reduced TAT AUC (30.6 vs 82.7 pmol \u00d7 h\/L), whereas the PROCR 655A&amp;gt;G effect reflected a lower APC AUC (8.6 vs 10.7 pmol \u00d7 h\/L). Ex vivo, the APC AUC\/thrombin AUC ratio was lower with previous VTE and PROCR 655A&amp;gt;G, higher with FVL, and not associated with THBD 1418C&amp;gt;T. No in vivo or ex vivo association was observed for PROCR 4678C&amp;gt;G. This study provides in vivo evidence that common THBD and PROCR variants modulate PC pathway function, establishing the APC response as a sensitive end point for subtle genetic effects beyond FVL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018733","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:46:43Z","timestamp":1784670403000},"page":"6818-6827","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["In vivo and ex vivo impact of\n                    <i>THBD<\/i>\n                    and\n                    <i>PROCR<\/i>\n                    polymorphisms on the anticoagulant response of the protein C pathway"],"prefix":"10.1182","volume":"10","author":[{"given":"Sara","family":"Reda","sequence":"first","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-1515","authenticated-orcid":false,"given":"Nadine","family":"Schwarz","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian F.","family":"Eckert","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-4100","authenticated-orcid":false,"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"P\u00f6tzsch","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-3424","authenticated-orcid":false,"given":"Behnaz","family":"Pezeshkpoor","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-2453","authenticated-orcid":false,"given":"Heiko","family":"R\u00fchl","sequence":"additional","affiliation":[{"name":"1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"},{"name":"2Institute for Clinical Hemostaseology and Transfusion Medicine, Saarland University, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"3","key":"2026101310432286600_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/ATVBAHA.111.242818","article-title":"Mechanistic view of risk factors for venous thromboembolism","volume":"32","author":"Reitsma","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2026101310432286600_bib2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41588-019-0519-3","article-title":"Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease","volume":"51","author":"Klarin","year":"2019","journal-title":"Nat Genet"},{"issue":"19","key":"2026101310432286600_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood.2019000435","article-title":"Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism","volume":"134","author":"Lindstr\u00f6m","year":"2019","journal-title":"Blood"},{"issue":"22","key":"2026101310432286600_bib4","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"2026101310432286600_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1538-7836.2003.00306.x","article-title":"Thrombomodulin","volume":"1","author":"Weiler","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2026101310432286600_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.ATV.0000134298.25489.92","article-title":"Thrombomodulin\u2013protein C\u2013EPCR system: integrated to regulate coagulation and inflammation","volume":"24","author":"Van de Wouwer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2026101310432286600_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"Blood"},{"issue":"0 1","key":"2026101310432286600_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jth.12247","article-title":"Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway","volume":"11 Suppl 1","author":"Bouwens","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"suppl 3","key":"2026101310432286600_bib9","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"issue":"13","key":"2026101310432286600_bib10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2017-12-823831","article-title":"In vivo thrombin generation and subsequent APC formation are increased in factor V Leiden carriers","volume":"131","author":"R\u00fchl","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2026101310432286600_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.119.315037","article-title":"Increased activated protein C response rates reduce the thrombotic risk of factor V Leiden carriers but not of prothrombin 20210G&gt;A carriers","volume":"125","author":"R\u00fchl","year":"2019","journal-title":"Circ Res"},{"issue":"5","key":"2026101310432286600_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3324\/haematol.2021.280573","article-title":"Impaired in vivo activated protein C response rates indicate a thrombophilic phenotype in inherited thrombophilia","volume":"107","author":"Reda","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"2026101310432286600_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/ATVBAHA.122.318433","article-title":"Ex vivo modeling of the PC (protein C) pathway using endothelial cells and plasma: a personalized approach","volume":"43","author":"Schwarz","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2026101310432286600_bib14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/ATVBAHA.113.301360","article-title":"Association of the thrombomodulin gene c.1418C&gt;T polymorphism with thrombomodulin levels and with venous thrombosis risk","volume":"33","author":"Navarro","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026101310432286600_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1538-7836.2003.00029.x","article-title":"Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE study","volume":"1","author":"Aleksic","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026101310432286600_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11239-015-1328-x","article-title":"Thrombomodulin gene c.1418C&gt;T polymorphism and risk of recurrent venous thromboembolism","volume":"42","author":"Ahmad","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"2026101310432286600_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jth.15630","article-title":"Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study","volume":"20","author":"Manderstedt","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026101310432286600_bib18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood-2003-07-2520","article-title":"A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis","volume":"103","author":"Saposnik","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2026101310432286600_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1160\/TH03-10-0657","article-title":"Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk","volume":"91","author":"Medina","year":"2004","journal-title":"Thromb Haemost"},{"issue":"10","key":"2026101310432286600_bib20","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2011-10-383448","article-title":"The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies","volume":"119","author":"Dennis","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2026101310432286600_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1055\/a-1738-1564","article-title":"Thrombotic risk determined by protein C receptor (PROCR) variants among middle-aged and older adults: a population-based cohort study","volume":"122","author":"Manderstedt","year":"2022","journal-title":"Thromb Haemost"},{"issue":"8","key":"2026101310432286600_bib22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1538-7836.2004.00855.x","article-title":"Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis","volume":"2","author":"Uitte de Willige","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026101310432286600_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/ATVBAHA.113.302518","article-title":"Functional analysis of two haplotypes of the human endothelial protein C receptor gene","volume":"34","author":"Medina","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026101310432286600_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/ATVBAHA.122.318433","article-title":"Ex vivo modeling of the PC (protein C) pathway using endothelial cells and plasma: a personalized approach","volume":"43","author":"Schwarz","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2026101310432286600_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/ATVBAHA.124.322116","article-title":"Endothelium modulates the prothrombotic phenotype of factor V Leiden: evidence from an ex vivo model","volume":"45","author":"Schwarz","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2026101310432286600_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jth.14479","article-title":"Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: communication from the SSC of the ISTH","volume":"17","author":"Megy","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2026101310432286600_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"2026101310432286600_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","article-title":"The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine","volume":"133","author":"Stenson","year":"2014","journal-title":"Hum Genet"},{"issue":"23","key":"2026101310432286600_bib29","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen--the Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"issue":"27","key":"2026101310432286600_bib30","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1002\/anie.201007032","article-title":"Profiling of active thrombin in human blood by supramolecular complexes","volume":"50","author":"M\u00fcller","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"2026101310432286600_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1538-7836.2012.04623.x","article-title":"Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay","volume":"10","author":"M\u00fcller","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026101310432286600_bib32","doi-asserted-by":"crossref","first-page":"102351","DOI":"10.1016\/j.rpth.2024.102351","article-title":"Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype","volume":"8","author":"Reda","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"2026101310432286600_bib33","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/nprot.2012.093","article-title":"Establishment of outgrowth endothelial cells from peripheral blood","volume":"7","author":"Martin-Ramirez","year":"2012","journal-title":"Nat Protoc"},{"key":"2026101310432286600_bib34","first-page":"e53384","article-title":"Generation and culture of blood outgrowth endothelial cells from human peripheral blood","volume":"106","author":"Ormiston","year":"2015","journal-title":"J Vis Exp"},{"issue":"4","key":"2026101310432286600_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.mbc.0000169218.15926.34","article-title":"A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjects","volume":"16","author":"Fridberg","year":"2005","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6818\/2593910\/blooda_adv-2025-018733-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6818\/2593910\/blooda_adv-2025-018733-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:43:33Z","timestamp":1791902613000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6818\/569786\/In-vivo-and-ex-vivo-impact-of-THBD-and-PROCR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":35,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018733","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,10,6]]}}}